Evan Y. Yu, Yue Song, Chris Garratt, Christian Heinrich Poehlein, Charles Schloss, Emmanuel S. Antonarakis. "OMAHA-003: A phase 3 study of CYP11A1 inhibitor opevesostat versus next-generation hormonal agent (NHA) switch in metastatic castration-resistant prostate cancer (mCRPC) after NHA and taxane-based chemotherapy.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps286